L Chaplin
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- Immune Response and Inflammation
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Protein purification and stability 2
-
- Monoclonal and Polyclonal Antibodies Research 7
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Andrew Nesbitt (4 shared papers)Mark Bodmer (2 shared papers)J.S. Emtage (2 shared papers)Sue Stephens (4 shared papers)Nick D. Jones (1 shared paper)Spencer Emtage (2 shared papers)Mark Sopwith (1 shared paper)C. R. Bebbington (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Journal of Chromatography A (2 papers)Clinical Chemistry (1 paper)Immunotechnology (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
L Chaplin
15 papers receiving 495 citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 280
- Immunology 132
- Immunology and Allergy 21
- Molecular Biology 238
- Oncology 79
Countries citing papers authored by L Chaplin
This map shows the geographic impact of L Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Chaplin more than expected).
Fields of papers citing papers by L Chaplin
This network shows the impact of papers produced by L Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Chaplin. The network helps show where L Chaplin may publish in the future.
Co-authors
The 25 scholars most cited alongside L Chaplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. | 1995 | 99 |
| 2 | The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding. | 1995 | 90 |
| 3 | 1991 | 62 | |
| 4 | 1994 | 52 | |
| 5 | 1996 | 44 | |
| 6 | 2002 | 35 | |
| 7 | 1991 | 32 | |
| 8 | 1986 | 27 | |
| 9 | 1995 | 21 | |
| 10 | 1985 | 21 | |
| 11 | 1987 | 14 | |
| 12 | 1997 | 9 | |
| 13 | 1998 | 4 | |
| 14 | 1988 | 4 | |
| 15 | Band-8 protein of human erythrocyte membrane: another Ca++ binding protein? | 1984 | 3 |
About L Chaplin
L Chaplin is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 517 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cell Adhesion Molecules Research (2 papers), HER2/EGFR in Cancer Research (2 papers), T-cell and B-cell Immunology (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (280 citations), Immunology (132 citations), Immunology and Allergy (21 citations), Molecular Biology (238 citations) and Oncology (79 citations). L Chaplin has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Andrew Nesbitt, Mark Bodmer, J.S. Emtage, Sue Stephens, Nick D. Jones, Spencer Emtage, Mark Sopwith, C. R. Bebbington, D. S. Athwal and RB Pedley. Their work appears in journals such as British Journal of Cancer, Journal of Chromatography A, Clinical Chemistry, Immunotechnology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.